Term Name: trans-rhaponticin
Synonyms: (2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol, (2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (E)-rhaponticin, 3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenyl beta-D-glucopyranoside, ponticin, rhaponticin, rhaponticine, rhapontin
Definition: A rhaponticin in which the double bond adopts a trans-configuration. It possesses a range of pharmacological activities including antitumour, antiinflammatory, antilipemic and neuroprotective activities.
Ontology: ChEBI [CHEBI:8824]  ( EBI )

Relationships
is a type of: rhaponticin
has_functional_parent: rhapontigenin
has_role: angiogenesis inhibitor anti-allergic agent anti-inflammatory agent antilipemic drug antineoplastic agent apoptosis inducer EC 2.3.1.85 (fatty acid synthase) inhibitor hypoglycemic agent neuroprotective agent plant metabolite
inverse has_functional_parent: 6-O-malonyl-trans-rhaponticin